SAM #36E79726R0025

Procurement of Mesalamine 1200mg Tablets for Federal Health Agencies

This opportunity involves the procurement of Mesalamine 1200mg Enteric Coated Delayed Release Tablets for federal health agencies: - Government Buyer: - Department of Veterans Affairs (VA), National Acquisition Center (OPAL National Acquisition Center) - Contracting office located in Hines, IL - Products Requested: - Mesalamine 1200mg Tablets, Enteric Coated (EC), Delayed Release (DR) - Packaged as 120 tablets per bottle - Estimated annual quantity: 107,364 bottles - Unique NDC number required for each offeror - Strict packaging and labeling requirements: - Safety cap - Specific bottle size and label dimensions - Only the offeror's label permitted on the product - Distribution Scope: - VA facilities (including Consolidated Mail Order Pharmacies and State Veterans Homes) - Department of Defense (DoD) facilities (including Tricare Mail Order Pharmacies) - Bureau of Prisons (BOP) - Indian Health Service (IHS) - Federal Health Care Center (FHCC) - Contract Structure: - One-year base period with four one-year option periods (up to five years total) - OEMs and Vendors: - No specific OEMs or vendors named; open to all qualified manufacturers meeting requirements - Notable Requirements: - Offerors must provide a unique NDC number - Product must meet all packaging and labeling specifications - Only the offeror's label may appear on the bottle

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0025 for an unrestricted procurement for Mesalamine 1200MG (1.2GM) Tablets Enteric Coated (EC) Delayed Release (DR) (Unit of Use), 120 Tablets per Bottle, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted item. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line item 1 120 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0025 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 25, 2026 with a tentative closing date of June 9, 2026 The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to Youlanda.Duggar@va.gov.
The estimated annual requirements are as follows:

REQUIREMENT DESCRIPTION DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) Mesalamine 1200MG (1.2GM) Tablets Enteric Coated (EC) Delayed Release (DR) (Unit of Use), 120 107,364

View original listing